Heunet Pharma
Heunet Pharma GmbH is a Nuremberg-based, wholly owned subsidiary of India's Torrent Group that markets and distributes finished pharmaceutical products into the German healthcare market, including co-distributed Heumann Pharma generics, selling through German channel partners.
- Company typePrivate
- Founded-
- HeadquartersNuremberg, Germany
- Headcount—
- GTM typeB2B
- OfferingHardware or Manufacturing
Heunet Pharma firmographics
Firmographics- Name
- Heunet Pharma
- Legal name
- Heunet Pharma GmbH
- Website
- https://heunet.de
- Company type
- Private
- Operating status
- Operating
- Short description
- Heunet Pharma GmbH is a Nuremberg-based, wholly owned subsidiary of India's Torrent Group that markets and distributes finished pharmaceutical products into the German healthcare market, including co-distributed Heumann Pharma generics, selling through German channel partners.
- Ownership category
- akta.pro rank
Heunet Pharma industry classification
Industry- Product category
- Pharmaceuticals (finished dosage forms) — marketing and distribution
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (4242), Wholesale Trade Agents and Brokers (4251)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro industry
- Full-Line Pharmaceutical WholesalersPrescription Pharmaceutical (Rx) Wholesale DistributionConsumer Products & Retail/Wholesale, Distribution & Category Management/Health, OTC & Pharmacy Wholesale DistributionSmall-Molecule Generics (Branded/Unbranded)Oral Solid Dose (OSD) Generics
Keywords
Where Heunet Pharma is headquartered
LocationHeadquarters
- HQ city
- Nuremberg
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Heunet Pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations
Revenue model
- Marketing and distribution of finished pharmaceutical products (finished drugs): Heunet Pharma earns revenue by marketing and selling finished pharmaceutical products (Fertigarzneimittel) to the German healthcare market. Revenue is product-transaction based, with margins tied to the purchase and resale economics of the medicines marketed, rather than recurring subscriptions or usage-based billing.
- Co-distribution of Heumann Pharma products: Heunet holds co-distribution rights (Mitvertriebsrecht) for the products of Heumann Pharma GmbH & Co. Generica KG, generating distribution-based revenue on branded and generic pharmaceutical products marketed into the German market.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels2 records
Heunet Pharma product offering
Product offeringCore offering
Heunet Pharma GmbH markets and sells finished pharmaceutical products (Fertigarzneimittel) for the German healthcare market. Its portfolio is supplied through its 100% parent, the Torrent Group (Ahmedabad, India), which the company states allows it to offer high-quality medicines on time and at favorable prices. Alongside its own range, it holds a co-distribution right (Mitvertriebsrecht) for the product portfolio of Heumann Pharma GmbH & Co. Generica KG, extending the generics offered into the German market.
Differentiator
Problem solved
Functional benefit
Products and services
- Heunet Pharma Finished Pharmaceutical Portfolio (Fertigarzneimittel) Heunet Pharma GmbH markets and sells numerous finished pharmaceuticals (finished dosage forms) for the German healthcare market, supplied and quality-assured through its 100% parent company, the Torrent Group (Ahmedabad, India), which the company states enables timely and competitively priced supply. The portfolio is supported by professional product information such as specialist information (Fachinformationen) and training materials, and trade terms are governed by published general terms and conditions (AGB).
- Heumann Pharma Co-Distribution Range Heunet Pharma GmbH holds a co-distribution right (Mitvertriebsrecht) for the products of Heumann Pharma GmbH & Co. Generica KG, extending its marketed portfolio with generics from the Heumann range for the German market. Detailed product information, including specialist information and training material where applicable, is published on heumann.de.
Companies that use Heunet Pharma
Customer profileSegments1 record
Ideal customer profiles1 record
Heunet Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Heunet Pharma partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered flagship / parent company — sole owner and core — co-distribution portfolio rights.
- Torrent Group (Torrent Pharma)flagship / parent company — sole ownerHeunet Pharma GmbH is a 100 percent subsidiary of the Torrent Group, a globally operating pharmaceutical corporation headquartered in Ahmedabad, India. This strong connection is stated to enable Heunet Pharma to offer high-quality medicines in a timely manner and at favorable prices. Further information about the Torrent Group is available at www.torrentpharma.com.
- Heumann Pharma GmbH & Co. Generica KGcore — co-distribution portfolio rightsHeunet Pharma GmbH holds a co-distribution right (Mitvertriebsrecht) for the products of Heumann Pharma GmbH & Co. Generica KG. Detailed product information such as specialist information and, where applicable, training materials can be found at www.heumann.de.
Scale indicators3 records
Heunet Pharma competitors and assessment
Company assessmentDirect peers
- Heumann Pharma GmbH & Co. Generica KG: German generics manufacturer whose product portfolio Heunet co-distributes (Mitvertriebsrecht) into the German healthcare market. It is the most directly comparable company: same German market, same generic-led finished-medicine portfolio, and an established German marketing and distribution footprint.
- ratiopharm: German-focused generics company with a large German field sales force marketing and distributing finished medicines to pharmacies, doctors and the wholesale channel. It competes for the same channel partners and the same German prescriber and pharmacy wallet as Heunet.
- HRA Pharma: German specialty pharmaceutical marketing and distribution company that brings third-party products into the German market via its own sales force and regulatory/medical-information infrastructure. Structurally very close to Heunet's marketing-and-distribution-plus-co-promotion model, though focused on specialty indications.
- Acino: Pharmaceutical commercial services and distribution partner that provides marketing, supply-chain and access services for manufacturers in European markets including Germany. Comparable for its hybrid model of owning or co-owning country-level product rights and running local commercial operations.
- Accord Healthcare: Generics-focused pharmaceutical group with substantial German operations supplying finished medicines to pharmacies and hospitals. It competes on the same product-and-price axis in Germany that Heunet's value proposition relies on, but with far greater scale.
- Zentiva: European generics manufacturer and distributor with a leading German presence built around a national sales and logistics network. Comparable to Heunet in the generic finished-medicine model and German market exposure, though it also owns manufacturing assets.
Broad incumbents
- Sandoz: Large global generics and biosimilars company with a top-tier German business across branded generics, biosimilars and OTC brands. It sets the price and service benchmark that Heunet's 'competitively priced' positioning is measured against, without sharing Heunet's focused, single-market distribution-only model.
- STADA Arzneimittel AG: German-headquartered branded and generic pharmaceutical group with deep German retail, pharmacy and wholesaler relationships. It is the incumbent whose scale and portfolio breadth define the competitive set Heunet sells into.
- Teva Pharmaceutical Industries: Global generics leader with one of the largest German generic footprints, competing directly for German tender and pharmacy volume. Relevant as the primary source of price and volume pressure on mid-sized generic marketing partners like Heunet.
- Recordati: European specialty pharmaceutical group with an active German business marketing branded and specialty medicines through dedicated German commercial operations. It illustrates the scaled, portfolio-owning end of the spectrum in which Heunet operates as a distributor-marketer.
Market position
Customer concentration
Heunet Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Heunet Pharma leadership team
Management profileNumber of profiles
Profiles1 record
Heunet Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Heunet Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Heunet Pharma
What does Heunet Pharma do?
Heunet Pharma GmbH markets and sells finished pharmaceutical products (Fertigarzneimittel) for the German healthcare market. Its portfolio is supplied through its 100% parent, the Torrent Group (Ahmedabad, India), which the company states allows it to offer high-quality medicines on time and at favorable prices. Alongside its own range, it holds a co-distribution right (Mitvertriebsrecht) for the product portfolio of Heumann Pharma GmbH & Co. Generica KG, extending the generics offered into the German market.
Is Heunet Pharma a public or private company?
Heunet Pharma is a private company. It is classified as corporate owned and is currently operating.
When was Heunet Pharma founded?
Heunet Pharma was founded in -1.
Where is Heunet Pharma based?
Heunet Pharma is headquartered in Nuremberg, Germany, in the Europe region.
How does Heunet Pharma make money?
Two revenue lines are on record. Marketing and distribution of finished pharmaceutical products (finished drugs) is the primary driver. The others are co-distribution of Heumann Pharma products.
Who are Heunet Pharma's main competitors?
Direct peers on record are Heumann Pharma GmbH & Co. Generica KG, ratiopharm, HRA Pharma, Acino, Accord Healthcare and Zentiva. Broad incumbents are Sandoz, STADA Arzneimittel AG, Teva Pharmaceutical Industries and Recordati.
Does Heunet Pharma have an API?
No public API is recorded for Heunet Pharma.
What industry is Heunet Pharma in?
Heunet Pharma's product category is Pharmaceuticals (finished dosage forms) — marketing and distribution. Its primary akta.pro industry code is HLAIAJAA, Full-Line Pharmaceutical Wholesalers, with a secondary code of CRAOAHAA, Prescription Pharmaceutical (Rx) Wholesale Distribution. Its NAICS code is 4242 and its SIC code is 5122.